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Francesco Donatelli, MD, a Michele Triggiani, MD, PhD, a Simona Nascimbene, MD, ~ Cristina Basso, MD, ~ 
Stefano Benussi, MD, a Sergio L. Chierchia, MD, FESC, FACC, b Gaetano Thiene, MD, c and 
Adalberto Grossi, MD, a Milan and Padua, Italy 
Coronary artery disease may rarely be due to vasculitis. 
Angina pectoris and acute myocardial infarction have 
been reported in patients with Takayasu's disease, polyar- 
teritis nodosa, and thromboangiitis obliterans. TM
In this article we report a case of Buerger's disease 
localized to coronary and internal thoracic arteries (ITAs) 
in a young nonsmoking woman. The diagnosis was made 
by histologic examination of the ITAs that were discarded 
at the time of bypass urgery. 
A 39-year-old woman had a 2-year history of epigasmc 
pain of unknown origin and sporadic episodes of typical 
angina for the past 8 months. Because of worsening of 
symptoms he underwent a treadmill exercise test. which 
showed signs of myocardial ischemia. The patient ap- 
peared to be otherwise in good health, without evidence 
of risk factors including diabetes mellitus, hypercholester- 
olemia, hypertension, besity, or family history of isch- 
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emic heart disease. She had never smoked. She never had 
aphthous ulcerations in the mouth or genitalia, nor had 
she a history of bronchial asthma, rash. fever, myalgia, or 
arthralgia. Routine blood assays were all within normal 
limits with the exception of the erythrocyte sedimentation 
rate (35 mm/hr). Because of unstable angina, the patient 
underwent cardiac catheterization, which showed severe 
left main disease (Fig. 1. A I and critical stenoses of the 
right coronary artery (Fig. 1, B) necessitating urgent 
myocardial revascularization. After a standard median 
sternotomy, both ITAs were dissected but were found to 
be unsuitable for grafting because of diffuse narrowing at 
the proximal end and occlusion at the distal end. More- 
over. satellite lymph nodes were enlarged. Three coronary 
arteries were bypassed with saphenous veins: the left 
anterior descending artery and the first obtuse marginal 
branch had a small caliber (<1.5 mm), and the posterior 
descending artery was thickened. The postoperative 
course was uneventful. 
Vascular specimens were examined histologically. The 
ITAs showed occlusion of the lumen owing to fibrous 
hyaline tissue with evidence of neovascularity, in keeping 
with an organized thrombus, with an intact internal elastic 
membrane and tunica media (Fig. 2, A). The vein speci- 
men showed intimal clusters of granulocytes with super- 
imposed mural thrombosis (Fig. 2. B). The artery and the 
veto were surrounded by fat with signs of periadventitial 
fibrosis involving neural structures and by lymph nodes 
Fig. 1. Angiograms in the left anterior oblique projection showing stenosis of the left main coronary artery 
(A) and the right coronary artery (B). 
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Fig. 2. Histotogic studies of the ITA and saphenous vein graft. A, ITA occluded by organized thrombosis 
with intact internal elastic lamina and tunica media (Weigert-Van Gieson stain; original magnification 
?<60). B, Vein with focal intimal abscess (Azan Mallory stain; original magnification ×100). 
with follicular hyperplasia. The diagnosis was consistent 
with thromboangiitis obliterans. Anti-core, anti-mitochon- 
drial, anti-smooth muscle, anti-cardiolipin, a ti-ribosome, 
and anti-reticulin antibodies and rheumatoid factor were 
not detected. Measurements ofC3 and C4 in the blood, as 
well as nephroscintigraphy, were within normal imits. 
At 8 months' follow-up the patient was doing well and 
was free of recurrent angina. Blood assays were within 
normal ranges with the exception of an elevated concen- 
tration of serum lipoprotein(a) (36.1 mg/dl with a cutoff of 
20 mg/dl). 
Buerger's disease may involve vessels other than 
those of the extremities. 5 Acute myocardial infarction 
owing to involvement of epicardial coronary arteries 
has been reported to be prevalent in affected patients. 6 
However, so far as we know, this is the first case of 
solitary localization of thromboangiitis obliterans in the 
chest involving both coronary arteries and ITAs. The 
diagnosis was made by histologic examination of ITAs 
discarded at operation, which showed thrombotic oc- 
clusion and intimal abscesses with an intact internal 
elastic lamina and tunica media. Before the operation, 
the diagnosis of Buerger's disease in this nonsmoking 
woman was unsuspected, because women are rarely 
affected by Buerger's disease 7 and smoking is consid- 
ered a major cause. However, histologic features were 
pathognomonic and other types of vasculitis (Behcet's 
disease, polyarteritis nodosa, Kawasaki's syndrome, 
vasculitis in systemic lupus erythematosus and rheuma- 
toid arthritis, Churg-Strauss disease, Takayasu's arteri- 
tis, and Wegener's granulomatosis) were excluded by 
clinical history, blood assays, and histologic studies. 
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Thromboangiitis obliterans is a nonatherosclerotic 
inflammatory occlusive vascular disease of unknown 
origin. In the absence of smoking, other risk factors, 
such as serum lipoprotein(a), must be considered in the 
pathogenesis of this disease. 8 Even though 8 months 
after the operation the patient had returned to her 
normal activities, the prognosis will be influenced by the 
potential, and previously reported occurrence of throm- 
boangiitis obliterans in the aorta-coronary saphenous 
vein grafts. 9
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ADDITIONAL POSTBYPASS ADMINISTRATION OF TRANEXAMIC ACID REDUCES BLOOD LOSS 
AFTER CARDIAC OPERATIONS 
Junya Katoh, MD, Kouji Tsuchiya, MD, Wataru Sato, MD, Masato Nakajima, MD, and Yoshinao Iida, MD, 
Yamanashi, Japan 
Excessive bleeding after cardiac operations involving 
cardiopulmonary b pass (CPB), mostly a result of acti- 
vated fibrinolysis and platelet dysfunction, remains a 
problem. Intraoperative administration of aprotinin sig- 
nificantly decreases postbypass blood loss; however, its 
use is limited because of complications such as inadequate 
heparinization during CPB and high cost. 1 Alternatively, 
Karski and associates 2 revealed that high-dose adminis- 
tration of tranexamic acid (TA) before CPB prevents 
excessive postoperative blood loss and reduces the need 
for blood transfusions. TA inhibits fibrinolysis by binding 
to the lysine binding site on plasminogen and plasmin, 
which is the binding site for fibrin. 
It was reported that to counteract post-CPB fibrinolytic 
status and achieve hemostasis, high-dose TA administra- 
tion was needed. 3 The elimination half-life of TA is about 
80 minutes. To maintain concentrations of TA in the 
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blood during hemostasis after CPB, we gave an additional 
half of the pre-CPB dose of TA during the post-CPB 
period. The objective of this study was to investigate 
whether an additional postbypass dose of TA affects 
post-CPB blood loss after cardiac operations. 
Methods. Ninety-three patients undergoing either cor- 
onary artery bypass grafting or heart valve operation were 
studied with their informed consent. Approval for the 
study was received from our hospital's ethics review 
board. Only one cardiac surgeon (K. T.) was involved in 
the study. In this prospective, randomized trial, the pa- 
tients were divided into three groups of equal size. Patient 
characteristics are summarized in Table I. 
All patients received high-dose fentawl anesthesia. Be- 
fore CPB was established, heparin. 200 IU/kg, was given 
intravenously toeach patient. Additional heparin was added 
throughout CPB to maintain the activated clotting time at 
more than 400 seconds. Heparin was neutralized with pro- 
tamine sulfate with the use of dose-response curves. Group 
TA-1 patients received an infusion of TA. 100 mg/kg, 
intravenously, over 20 minutes oon after induction of anes- 
thesia and before CPB. Group TA-2 patients received a 100 
mg/kg dose of TA. like the group TA-1 patients, and an 
additional TA dose of 50 mg/kg infused intravenously over 
20 minutes soon after being weaned from CPB. Control 
group patients received conventional perioperative therapy. 
Red blood cells (RBCs) were transfused for a hemoglobin 
threshold of 75 gm/L or less. Mediastinal blood loss during 
the operation, but after discontinuation f CPB. and drain- 
